PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 250 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,445,000 | +113.8% | 45,145 | +68.5% | 0.64% | +67.8% |
| Q3 2020 | $1,611,000 | -17.3% | 26,798 | -27.8% | 0.38% | -11.4% |
| Q2 2020 | $1,949,000 | -35.0% | 37,137 | -4.8% | 0.43% | +9.9% |
| Q4 2015 | $2,997,000 | +64.0% | 39,026 | +89.4% | 0.39% | +53.7% |
| Q4 2014 | $1,827,000 | +3.2% | 20,604 | +12.8% | 0.26% | -29.2% |
| Q3 2014 | $1,770,000 | -16.9% | 18,264 | -21.3% | 0.36% | -10.9% |
| Q2 2014 | $2,131,000 | -11.7% | 23,201 | -32.7% | 0.40% | -7.1% |
| Q1 2014 | $2,412,000 | +2.8% | 34,455 | -15.6% | 0.44% | +3.6% |
| Q4 2013 | $2,347,000 | -20.7% | 40,829 | -33.6% | 0.42% | -28.8% |
| Q3 2013 | $2,958,000 | +57.8% | 61,515 | -4.8% | 0.59% | +45.0% |
| Q2 2013 | $1,875,000 | – | 64,641 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |